Table W1. Statistical Differential Genes  Classified According to the Venn?s Diagram (Figure 2).

Table 1. Putative c-Rel targets derived from expression profiling of EDI MoDCs

Supplementary Table1. Upregulated (>2.0) genes in both Huh7 and PLC/PRF/5 SP cells

Table 2. Genes with unique gene-expression profile in WM

Table 3. Genes with unique expression profile in CLL

Table 4. Genes with unique expression profile in MM

Annotated list of 276 HRT- related genes. HRTrelated_GeneList.xls is an Excel spreadsheet containing the age-adjusted list of HRT-related genes  with links to EntrezGene and GenBank at NCBI. See SupplementaryReport. pdf for description.

TABLE SI. Effect of NUP98-HOXA9 on gene transcription at 6 h after transfection

TABLE S2. Effect of NUP98-HOXA9 on gene transcription at 3 d after transduction

TABLE S3. Effect of NUP98-HOXA9 on gene transcription at 8 d after transduction

Table 1. TSA or 5-AzaC treatment induces widespread up-regulation of genes across several important regulatory pathways

Table 1. Selected genes up-regulated or down-regulated by sustained EGR-1 expression as delineated from Affymetrix microarray analysis

Supplementary Table 2: Genes upregulated by EGR-1 over 25 fold 24 h post-infection (67 genes)

Table 3. One hundred twenty-nine genes whose increased expression was associated with progression of dysplasia

Table 2. Twenty genes whose increased expression was associated with regression of dysplasia

Table 2C (Top 200 genes which discriminate between BRCA1 & BRCA2 genotypes: SVM)

Table 2B (Top 200 BRCA2 genotype predictor genes: SVM)

Table 2A (Top 200 BRCA1 genotype predictor genes: SVM)

Table 2. List of the top 20 genes identified in a matched-pair analysis differentially expressed between initial diagnosis and relapse (32 precursor B-ALL)

Supplementary Table S4. Genes differentially expressed  between PAX-FKHR and fusion-negative RMS cell lines

Supplementary Table S3. Genes differentially expressed  between PAX-FKHR polyclones and vector controls

Supplementary Table S2. Meta-clustering derived gene list from primary tumor analysis.